Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
KBP Biosciences (Singapore)
Homepage:
kbpbio.com
Alternate names:
KBP Biosciences,
KBP Biosciences Co., Ltd.,
KBP Biosciences Pte. Ltd.,
KBP Biosciences USA Inc.
ROR:
013awcs65
OpenAlex ID:
I4405267070
Effect of KBP-5074 on Blood Pressure in Advanced Chronic Kidney Disease: Results of the BLOCK-CKD Study
2021
·
George Bakris
, Pablo E. Pergola
, et al.
·
Hypertension
·
122
Phase II study of vemurafenib followed by ipilimumab in patients with previously untreated BRAF-mutated metastatic melanoma
2016
·
Asim Amin
, David H. Lawson
, et al.
·
Journal for ImmunoTherapy of Cancer
·
68
PDF
Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease: BLOCK-CKD Trial
2020
·
George Bakris
, Y. Fred Yang
, et al.
·
Hypertension
·
50
PDF
Beware of on-treatment safety analyses
2018
·
Fred Yang
, Janet Wittes
, et al.
·
Clinical Trials
·
33
PDF
In Vitro Activity of KBP-7072, a Novel Third-Generation Tetracycline, against 531 Recent Geographically Diverse and Molecularly Characterized Acinetobacter baumannii Species Complex Isolates
2020
·
Michael D. Huband
, Rodrigo E. Mendes
, et al.
·
Antimicrobial Agents and Chemotherapy
·
30
Efficacy and Safety of Ocedurenone: Subgroup Analysis of the BLOCK-CKD Study
2023
·
George L Bakris
, Y Fred Yang
, et al.
·
American Journal of Hypertension
·
22
PDF
In Vitro Activity of KBP-7072 against 536 Acinetobacter baumannii Complex Isolates Collected in China
2022
·
Renru Han
, Li Ding
, et al.
·
Microbiology Spectrum
·
18
The Non-Steroidal Mineralocorticoid Receptor Antagonist KBP-5074 Limits Albuminuria and has Improved Therapeutic Index Compared With Eplerenone in a Rat Model With Mineralocorticoid-Induced Renal Injury
2021
·
Frédéric Jaisser
, Xiaojuan Tan
, et al.
·
Frontiers in Pharmacology
·
18
PDF
Activity of the Novel Aminomethylcycline KBP-7072 and Comparators against 1,057 Geographically Diverse Recent Clinical Isolates from the SENTRY Surveillance Program, 2019
2021
·
Michael D. Huband
, Jennifer D. Thompson
, et al.
·
Antimicrobial Agents and Chemotherapy
·
14
Approaching the active conformation of 1,3-diaminopyrimidine based covalent inhibitors of Bruton’s tyrosine kinase for treatment of Rheumatoid arthritis
2016
·
Zhenhua Huang
, Qian Zhang
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
12
The third-generation tetracycline, KBP-7072, exploits and reveals a new potential of the primary tetracycline binding pocket
2018
·
Tatsuya Kaminishi
, Andreas Schedlbauer
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
11
PDF
In vivo efficacy and PK/PD analyses of zifanocycline (KBP-7072), an aminomethylcycline antibiotic, against Acinetobacter baumannii in a neutropenic murine thigh infection model
2023
·
Li Li
, Xiaojuan Tan
, et al.
·
Journal of Infection and Chemotherapy
·
10
Multiple Ascending Dose Safety, Tolerability, and Pharmacokinetics of KBP-7072, a Novel Third-generation Tetracycline
2017
·
Fred Yang
, Yanli Wang
, et al.
·
Open Forum Infectious Diseases
·
10
PDF
Single Ascending Dose Safety, Tolerability, and Pharmacokinetics of KBP-7072, a Novel Third Generation Tetracycline
2016
·
Bin Zhang
, Yanli Wang
, et al.
·
Open Forum Infectious Diseases
·
10
PDF
Pharmacokinetics and Drug–Drug Interaction of Ocedurenone (KBP-5074) in vitro and in vivo
2023
·
Ping Wang
, Jinrong Liu
, et al.
·
European Journal of Drug Metabolism and Pharmacokinetics
·
8
PDF
In vitro activity of a novel aminomethylcycline antibacterial (KBP-7072), a third-generation tetracycline, against clinical isolates with molecularly characterized tetracycline resistance mechanisms
2021
·
Michael A Pfaller
, Li Li
, et al.
·
JAC-Antimicrobial Resistance
·
7
Nonclinical Pharmacokinetics, Protein Binding, and Elimination of KBP-7072, an Aminomethylcycline Antibiotic, in Animal Models
2020
·
Xiaojuan Tan
, Min Zhang
, et al.
·
Antimicrobial Agents and Chemotherapy
·
7
In vitro activity of KHP-3757 (a novel LpxC inhibitor) and comparator agents against recent and molecularly characterized Pseudomonas aeruginosa isolates from a global surveillance program (2017–2018)
2020
·
Michael D. Huband
, Jill M. Lindley
, et al.
·
Diagnostic Microbiology and Infectious Disease
·
3
Pharmacokinetics of the Novel Nonsteroidal Mineralocorticoid Receptor Antagonist Ocedurenone (KBP-5074) in Individuals with Moderate Hepatic Impairment
2024
·
James McCabe
, Jay Zhang
, et al.
·
European Journal of Drug Metabolism and Pharmacokinetics
·
2
PDF
Safety and Pharmacokinetics of a Novel Non-Steroidal Mineralocorticoid Receptor Antagonist, KBP-5074, in Hemodialysis and Non-Hemodialysis Patients with Severe Chronic Kidney Disease
2020
·
Jeffrey Connaire
, Mark Bush
, et al.
·
medRxiv
·
2
PDF
In Vivo Efficacy and PK/PD Modeling of KBP-7072, An Aminomethylcycline Antibiotic, in Neutropenic Pneumonia and Thigh Infection Models
2020
·
Xiaojuan Tan
, Min Zhang
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
·
1
PDF
Abstract 13183: The Burden of Uncontrolled Hypertension (HTN) in Chronic Kidney Disease (CKD). Impact of the Revised KDIGO Guidelines
2023
·
Richard McGregor
, Y Fred F Yang
, et al.
·
Circulation
Abstract P322: Absorption, Metabolism, And Elimination Of Nonsteroidal Mineralocorticoid Receptor Antagonist Ocedurenone In Humans
2023
·
Fred Yang
, Judy Tan
, et al.
·
Hypertension
Abstract 13133: Effect of Ocedurenone in Patients With Uncontrolled Hypertension and Stage 3b/4 Chronic Kidney Disease - Subgroup Analysis of a Phase 2b Clinical Trial
2022
·
June Ye
, James McCabe
, et al.
·
Circulation
KBP-5074, a Nonsteroidal Mineralocorticoid Receptor Antagonist, Reduces Urine Albumin-to-Creatinine Ratio and the Risk of Hyperkalemia in an Animal Model of CKD
2020
·
Frederic Jaisser
, Liu Jinrong
, et al.
·
Journal of the American Society of Nephrology
Show more works
View as search
Works count:
25
Citation count:
458
Year
Topic
Type